# GL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ Cancers

> **NCT02714374** · PHASE1 · TERMINATED · sponsor: **Andrew Lowy** · enrollment: 5 (actual)

## Conditions studied

- Solid Organ Cancers

## Interventions

- **BIOLOGICAL:** GL-ONC1

## Key facts

- **NCT ID:** NCT02714374
- **Lead sponsor:** Andrew Lowy
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-03-25
- **Primary completion:** 2019-08-06
- **Final completion:** 2019-08-06
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Insufficient funding
- **Last updated:** 2024-08-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02714374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02714374, "GL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ Cancers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02714374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*